Polyphor AG | WebDisclosure

Switch to English

9807	Sociétés
196783	Mots-clés
127785	Articles
104617	Communiqués

Accueil
Sociétés
Polyphor AG

COMMUNIQUÉ DE PRESSE

publié le 30/04/2024 à 20:30, il y a 1 année 9 mois

Spexis receives approval of an extension of the deadline for the publication of its 2023 annual report and audited financials until latest May 31, 2024.
Spexis AG receives approval to extend deadline for publishing 2023 annual report and audited financials until May 31, 2024, due to ongoing legal discussions and negotiations with creditors

Extension 2023 Annual Report Spexis AG Deadline Audited Financials
BRÈVE

publiée le 17/04/2024 à 07:20, il y a 1 année 9 mois

Spexis AG annonce des développements importants, notamment un moratoire prolongé et des modifications stratégiques en matière de licences

Spexis SA Prolongation Du Moratoire OMPTA Vente De Programmes Précliniques Licence Lonodelestat
BRÈVE

publiée le 17/04/2024 à 07:20, il y a 1 année 9 mois

Spexis AG Announces Significant Developments Including Extended Moratorium and Strategic Licensing Changes

Spexis AG Moratorium Extension OMPTAs Preclinical Program Sale Lonodelestat Licensing
COMMUNIQUÉ DE PRESSE

publié le 17/04/2024 à 07:15, il y a 1 année 9 mois

Spexis announces extension of moratorium, receipt of an additional payment related to the sale of a preclinical antibiotics program and reversion of the lonodelestat license from Santhera
Spexis AG extends moratorium and receives payment for antibiotics program sale while reverting lonodelestat license from Santhera

Spexis AG Moratorium Extension Antibiotics Program Sale Lonodelestat License Santhera
COMMUNIQUÉ DE PRESSE

publié le 08/02/2024 à 07:15, il y a 1 année 11 mois

Spexis announces closing of sale of preclinical antibiotics program to Basilea
Spexis AG announces the closing of the sale of a preclinical antibiotics program to Basilea, which will pay up to CHF 2 million for the program. The program targets Gram-negative bacteria, including multidrug-resistant strains. The sale is part of Spexis' strategy to divest non-core programs and assets to focus on rare diseases and oncology

Spexis AG Basilea Preclinical Antibiotics Program Gram-negative Bacteria Multidrug-resistant Strains
COMMUNIQUÉ DE PRESSE

publié le 08/11/2023 à 07:15, il y a 2 années 2 mois

Spexis to file an application for a debt-restructuring moratorium
COMMUNIQUÉ DE PRESSE

publié le 01/11/2023 à 07:20, il y a 2 années 3 mois

Spexis Announces Changes to the Executive Committee
COMMUNIQUÉ DE PRESSE

publié le 06/10/2023 à 07:30, il y a 2 années 3 mois

Spexis to host business update conference call on October 9, 2023
COMMUNIQUÉ DE PRESSE

publié le 29/09/2023 à 07:25, il y a 2 années 4 mois

Spexis provides business update and announces financial results for the first half of 2023
COMMUNIQUÉ DE PRESSE

publié le 28/09/2023 à 07:30, il y a 2 années 4 mois

Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology

Les Echos

Publié le 05/02/2026 à 11:30, il y a 2 heures 20 minutes

Déclaration nombre d'actions et droits de vote - 05.02.2026
Publié le 05/02/2026 à 11:30, il y a 2 heures 20 minutes

Disclosure of shares outstanding and voting rights - 05.02.2026
Publié le 04/02/2026 à 18:04, il y a 19 heures 46 minutes

Capital et droits de vote au 31 janvier 2026
Publié le 04/02/2026 à 18:04, il y a 19 heures 46 minutes

Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 20 heures 5 minutes

Information concerning the total number of voting rights and shares 2026 01 31

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 05/02/2026 à 13:30, il y a 20 minutes

Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
Publié le 05/02/2026 à 13:30, il y a 20 minutes

ESGold Expands Montauban Land Position Following 3D Geological Model Identifying Potential District-Scale Mineralized Corridor
Publié le 05/02/2026 à 13:20, il y a 30 minutes

Guanajuato Silver Sees Significant Growth in Resources at Valenciana
Publié le 05/02/2026 à 13:15, il y a 35 minutes

Avino Appoints Linda Broughton to The Board of Directors
Publié le 05/02/2026 à 13:00, il y a 50 minutes

urban-gro to Implement 1-for-25 Reverse Stock Split

Voir tout ACCESSWIRE

EQS Group

Publié le 05/02/2026 à 13:30, il y a 20 minutes

Ascory Bank ends its year of transformation in 2025 with positive results and starts 2026 with a new strategy and a new name
Publié le 05/02/2026 à 13:04, il y a 46 minutes

EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Publié le 05/02/2026 à 12:48, il y a 1 heure 2 minutes

Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Publié le 05/02/2026 à 12:45, il y a 1 heure 5 minutes

R.E.A. Holdings plc: Notification of Major Holdings
Publié le 05/02/2026 à 11:47, il y a 2 heures 3 minutes

Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE